跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
普米克令舒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Budesonide Suspension for Inhalation
Approved
化学药品
Budesonide Suspension for Inhalation
ASTRAZENECA PTY LTD
🇨🇳 National Medical Products Administration
Approval Date
Nov 30, 2023
Approval ID
8YaxMDojDio
Company
ASTRAZENECA PTY LTD
Type
化学药品
Approval Details
Approval Id
8YaxMDojDio
Approval Number
国药准字HJ20140474
Generic Name
吸入用布地奈德混悬液
Generic Name En
Budesonide Suspension for Inhalation
Trade Name
普米克令舒
Drug Type
化学药品
Dosage Form
吸入混悬液
Strength
2ml:0.5mg
Reg Date
2023-11-30
Expired Date
2028-11-29
Company Name
ASTRAZENECA PTY LTD
Production Company Name
ASTRAZENECA PTY LTD
Company Detail Path
/organization/astrazeneca-pty-ltd
Production Company Detail Path
/organization/astrazeneca-pty-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 30, 2023
Approval ID
8YaxMDojDio
Type
化学药品
Back to NMPA Approvals